1
|
Zur Hausen H: Papillomaviruses in the
causation of human cancers – a brief historical account. Virology.
44:219–224. 2009.
|
2
|
Senba M, Mori N and Wada A: Oncogenesis of
and the link between inflammation and cancer due to human
papillomavirus (HPV) infectionand the development of vaccine
control strategies. Cancer Res J. 2:307–338. 2009.
|
3
|
Smith JS, Herrero R, Bosetti C, et al:
Herpes simplex virus-2 as a human papillomavirus cofactor in the
etiology of invasive cervical cancer. J Natl Cancer Inst.
94:1604–1613. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Smith JS, Munoz N, Herrero R, et al:
Evidence for Chlamydia trachomatis as a human papillomavirus
cofactor in the etiology of invasive cervical cancer in Brazil and
the Philippines. J Infect Dis. 185:324–331. 2002.
|
5
|
Lu H, Ouyang W and Huang C: Inflammation,
a key event in cancer development. Mol Cancer Res. 4:221–233. 2006.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Hussain SP and Harris CC: Inflammation and
cancer: an ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Karin M and Greten FR: NF-κB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005.
|
8
|
Karin M: Nuclear factor-κB in cancer
development and progression. Nature. 441:431–436. 2006.
|
9
|
Schottenfeld D and Beebe-Dimmer J: Chronic
inflammation: a common and important factor in the pathogenesis of
neoplasia. CA Cancer J Clin. 56:69–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kleter B, Doorn LJ, Schegget J, et al:
Novel short-fragment PCR assay for highly sensitive broad-spectrum
detection of anogenital human papillomaviruses. Am J Pathol.
135:1731–1739. 1998. View Article : Google Scholar : PubMed/NCBI
|
11
|
Picconi MA, Ejian AM, Distefano AL, et al:
Human papillomavirus (HPV) DNA in penile carcinomas in Argentina:
analysis of primary tumors and lymph nodes. J Med Virol. 61:65–69.
2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Senba M, Kumatori A, Fujita S, et al: The
prevalence of human papilomavirus genotypes in penile cancers from
northern Thailand. J Med Virol. 78:1341–1346. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sarkar FH, Miles BJ, Plieth DH and
Crissman JD: Detection of human papillomavirus in squamous neoplasm
of the penis. J Urol. 147:389–392. 1992.PubMed/NCBI
|
14
|
Tornesello ML, Buonaguro FM, Beth-Giraldo
E, Kyalwazi SK and Giraldo G: Human papillomavirus (HPV) DNA in
penile carcinomas and two cell lines from high-incidence area for
genital cancers in Africa. Int J Cancer. 51:587–592. 1992.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Senba M, Buziba N, Mori N, Wada A, Irie S
and Toriyama K: Detection of human papillomavirus and cellular
regulators p16INK4a, p53, and NF-κB in penile cancer
cases in Kenya. Acta Virol. 53:43–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Cupp MR, Malek RS, Goellner JR, Smith TF
and Espy MJ: The detection of human papillomavirus deoxyribonucleic
acid in intraepithelial, in situ, verrucous and invasive carcinoma
of the penis. J Urol. 154:1024–1029. 1995. View Article : Google Scholar : PubMed/NCBI
|
17
|
Tornesello ML, Duraturo ML, Losito S, et
al: Human papillomavirus genotypes and HPV 16 variants in penile
carcinoma. Int J Cancer. 122:132–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Rubin MA, Kleter B, Zhou M, et al:
Detection and typing of human papillomavirus DNA in penile
carcinoma: evidence for multiple independent pathways of penile
carcinogenesis. Am J Pathol. 159:1211–1218. 2001. View Article : Google Scholar
|
19
|
Cubilla AL, Reuter VE, Gregoire L, et al:
Basaloid squamous cell carcinoma: a distinctive human papilloma
virus-related penile neoplasm. A report of 20 cases. Am J Surg
Pathol. 22:755–761. 1998. View Article : Google Scholar : PubMed/NCBI
|
20
|
Gross G and Pfister H: Role of human
papillomavirus in penile cancer, penile intraepithelial squamous
cell neoplasia and in genital warts. Med Microbiol Immunol.
193:35–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Gregoire L, Cubilla AL, Reuter VE, Haas GP
and Lancaster WD: Preferential association of human papillomavirus
with high-grade histological variants of penile invasive squamous
cell carcinoma. J Natl Cancer Inst. 87:1705–1709. 1995. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kiriakidis S, Andreakos E, Monaco C,
Foxwell B, Feldmann M and Paleolog E: VEGF expression in human
macrophages is NF-κB-dependent: studies using adenoviruses
expressing the endogenous NF-κB inhibitor IκBα and kinase-defective
form of the IκB kinase 2. J Cell Sci. 116:665–674. 2003.
|
23
|
Nees M, Geoghegan JM, Hyman T, Frank S,
Miller L and Woodworth CD: Papillomavirus type 16 oncogenes
downregulate expression of interferon-responsive genes and
upregulate proliferation-associated and NF-κB-responsive genes in
cervical keratinocytes. J Virol. 75:4283–4296. 2001.PubMed/NCBI
|
24
|
Spitkovsky D, Hehner SP, Hofmann TG,
Moller A and Schmitz ML: The human papillomavirus oncoprotein E7
attenuates NF-κB activation by targeting IκB kinase complex. J Biol
Chem. 277:25576–25582. 2002.PubMed/NCBI
|
25
|
Havard L, Delvenne P, Frare P, Boniver J
and Giannini SL: Differential production of cytokines and
activation of NF-κB in HPV transformed keratinocytes. Virology.
298:271–285. 2002.
|
26
|
Havard L, Rahmouni S, Boniver J and
Delvenne P: High levels of p105 (NFκB1) and p100 (NFκB2) proteins
in HPV 16-transformed keratinocytes: role of E6 and E7
oncoproteins. Virology. 331:357–366. 2005.
|
27
|
Mishra A, Bharti AC, Varghese P, Saluja D
and Das BC: Differential expression and activation of NF-κB family
proteins during oral carcinogenesis: role of high risk human
papillomavirus infection. Int J Cancer. 119:2840–2850. 2006.
|
28
|
James MA, Lee JH and Klingelhutz AJ: Human
papillomavirus type 16 E6 activates NF-κB, induces cIAP-2
expression and protects against apoptosis in a PDZ binding
motif-dependent manner. J Virol. 80:5301–5307. 2006.
|